STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Income Statement [Abstract] | ||
| Revenue | $ 8 | |
| Operating expenses: | ||
| Research and development | $ 19,436 | 3,660 |
| Sales and marketing | 2,336 | 216 |
| General and administrative | 8,788 | 2,455 |
| Total operating expenses | 30,560 | 6,331 |
| Loss from operations | (30,560) | (6,323) |
| Interest expense, net | (185) | (100) |
| Gain on Loan Forgiveness | 647 | |
| Change in fair value of SAFEs | (10,390) | 189 |
| Loss before provision for (benefit from) income taxes | (40,488) | (6,234) |
| Provision for (benefit from) income taxes | (153) | 153 |
| Net loss | (40,335) | (6,387) |
| Cumulative preferred dividends allocated to Series A Preferred Shareholders | (1,507) | |
| Net loss attributable to common shareholders, basic and diluted | $ (40,335) | $ (7,894) |
| Net loss per share attributable to common shareholders, basic and diluted | $ (3.11) | $ (0.79) |
| Weighted-average shares used in computing net loss per share | 12,982,472 | 9,949,376 |